Yuan Lu

Dr. Yuan Lu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2024 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
XDXinjia Du
Xinjia Du
JLJiahua Liu
Jiahua Liu
JZJingfang Zhou
Jingfang Zhou
YRYanfei Ren
Yanfei Ren
NGNauman Gul
Nauman Gul
YLYuan Lu
Yuan Lu
Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes. Soluble suppression of tumorigenicity 2 (sST2) serves as a biomarker for inflammation and myocardial fibrosis. Yet, the correlation between sST2 and MVO in STEMI patients has not been fully elucidated. This study attempts to evaluate the association between sST2 levels and MVO in STEMI patients following pPCI. In this retrospective study, 315 STEMI patients who underwent pPCI at the Affiliated Hospital of Xuzhou Medical University between June 2018 and August 2023 were included. Cardiac magnetic resonance imaging (CMR) was used to assess the characteristics of myocardial infarction and microvascular obstruction (MVO), while sST2 levels were measured upon admission. The median time for completion of CMR after hospitalization was 5 (4, 6) days. Multivariate regression analysis showed that sST2 (OR 1.01, 95% CI 1.01–1.02, p < 0.001), peak high-sensitivity troponin T (OR 2.40, 95% CI 1.66–3.47, p < 0.001), peak high-C-reactive protein (OR 1.01, 95% CI 1.01–1.02, p < 0.001), left ventricular ejection fraction (OR 0.93, 95% CI 0.89– 0.98, p = 0.009) and age (OR 1.03, 95% CI 1.01– 1.05, p = 0.042)were independently associated with MVO. sST2 is associated with MVO after pPCI in STEMI patients. Incorporating soluble ST2 (sST2) into the risk model for MVO leads to significant improvement.

8 April 2024 in International Journal of Cardiology
Verified
Journal Article
Closed access
YRYanfei Ren
Yanfei Ren
LCLei Chen
Lei Chen
JLJiahua Liu
Jiahua Liu
YWYixuan Wu
Yixuan Wu
XDXinjia Du
Xinjia Du
YLYuan Lu
Yuan Lu

9 May 2025 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
YWYixuan Wu
Yixuan Wu
JLJiahua Liu
Jiahua Liu
XDXinjia Du
Xinjia Du
MLMaochen Li
Maochen Li
YRYanfei Ren
Yanfei Ren
YLYuan Lu
Yuan Lu

20 January 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
YRYanfei Ren
Yanfei Ren
XDXinjia Du
Xinjia Du
MLMaochen Li
Maochen Li
LCLei Chen
Lei Chen
JLJiahua Liu
Jiahua Liu
YLYuan Lu
Yuan Lu
Previous studies have shown that epicardial edipose tissue(EAT) appears to be associated with myocardial inflammation and fibrosis, but this is not clear in patients with new-onset atrial arrhythmias after STEMI. The present study focused on using CMR to assess the association of epicardial fat with myocardial inflammation and fibrosis and its predictive value in patients with new-onset atrial arrhythmias after STEMI. This was a single-centre, retrospective study. We consecutively selected patients who completed CMR during their hospitalisation for PCI after STEMI from May 2019-January 2023, and then underwent regular follow-up, grouped by the presence or absence of new atrial arrhythmias, and enrolled patients were divided into atrial arrhythmia and non-atrial arrhythmia groups. In the atrial arrhythmia group, age, heart rate, Peak hs-TnT, PeakNT-proBNP, EATV, LAES, LAED, T1 native, T1*, ECV, and T2 were higher than those in the non-atrial arrhythmia group, and LVEF was lower than those in the non-atrial arrhythmia group. EATV showed a positive and significant correlation with T1native, T1*, ECV, and T2. (T1 native: r = 0.476,p < 0.001; ECV: r = 0.529,p < 0.001; T1*: r = 0.467,p < 0.001; T2: r = 0.538,p < 0.001). Multifactorial logistic regression analysis showed age, LVEF, EATV, T1*,ECV, T2 as independent risk factors for atrial arrhythmia. (p < 0.05) ROC analysis showed that the AUC for age was 0.568; AUC for LVEF was 0.656; AUC for EATV was 0.768; AUC for ECV was 0.705; AUC for T1* was 0.612; and AUC for T2 was 0.772. In patients with STEMI, EAT is associated with myocardial inflammation, fibrosis. Age, LVEF, EATV, T1*,ECV, T2 are independent risk factors for new onset atrial arrhythmias and have good predictive value.

21 April 2025 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
YWYiwen Wang
Yiwen Wang
HSHaowen Shi
Haowen Shi
MZMin Zhang
Min Zhang
YDYang Duan
Yang Duan
ZLZhi Li
Zhi Li
YLYuan Lu
Yuan Lu
BACKGROUND:The COVID-19 pandemic accelerated the adoption of home-based cardiac telerehabilitation (HBCTR), yet evidence on the role of intensified self-management in outcomes for acute coronary syndrome (ACS) patients remains limited. MATERIAL AND METHODS:In this single-center retrospective cohort study (2019-2021), 1627 ACS patients were stratified into 2 groups: those who finished a self-management-centric HBCTR (SMCCRF) plan, and the SMCCR-unfinished (SMCCRNF) group (≥1 missed tele-coaching sessions). The primary outcome was major adverse cardiac events (MACEs); secondary outcomes included self-perceived disease awareness assessed by the Coronary Artery Disease Education Questionnaire-Short Version (CADEQ-SV), behavioral metrics (medication adherence, physical exercise), and risk factor control. Propensity score matching (1: 1, calliper=0.1 standard deviation) generated 619 matched pairs. RESULTS:Over a median follow-up of 23.39 months, the SMCCRF group had lower MACEs rates compared to the SMCCRNF group (7.43% vs 18.74%; HR 0.43, 95% CI 0.30-0.60; P<0.001), with consistent benefits across subgroups. Secondary outcomes favored the SMCCRF group, including higher CADEQ-SV scores at 12 and 36 months (P=0.02), better medication and exercise adherence (both P<0.001), and improved control of blood pressure, low-density lipoprotein cholesterol, and smoking cessation (all P<0.01). However, changes in cardiac function were similar between the 2 groups, and fluctuations of the aforementioned secondary outcomes were observed during long-term follow-up. CONCLUSIONS:SMCCR was associated with reduced cardiovascular risk and enhanced behavioral outcomes in ACS patients during the pandemic, suggesting a dose-dependent relationship between missed sessions and adverse outcomes. The findings support integrating self-management strategies into post-ACS care, pending validation in prospective trials.

26 March 2025 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
JLJiahua Liu
Jiahua Liu
XDXinjia Du
Xinjia Du
YRYanfei Ren
Yanfei Ren
YMYan Mei
Yan Mei
LCLei Chen
Lei Chen
YLYuan Lu
Yuan Lu
Background: Current research suggests that microvascular obstruction (MVO) following the first percutaneous coronary intervention (PCI) in myocardial infarction patients is closely related to inflammatory responses. The lymphocyte-to-C-reactive protein (CRP) ratio (LCR), as a novel inflammatory marker, is associated with the prognosis of patients with ST-segment elevation myocardial infarction (STEMI). However, the relationship between LCR and MVO remains unclear. This study aims to investigate the correlation between LCR and MVO in STEMI patients undergoing PCI.Methods: This was a single-center retrospective study. We consecutively enrolled STEMI patients who underwent PCI at Xuzhou Medical University Affiliated Hospital, Xuzhou, China, from September 2019 to December 2023. Cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) was used to assess infarct size and the presence of MVO.Results: A total of 551 patients were included in this study, with 267 (48.5%) experiencing MVO. The median time for CMR imaging-based detection of MVO was 5 days (interquartile range: 4, 6). Univariate regression analysis revealed that age, white blood cell count, neutrophil count, left ventricular ejection fraction (LVEF), peak N-terminal pro-B-type natriuretic peptide (NT-proBNP), peak high-sensitivity troponin T (hs-TnT), LCR, LGE percentage (LGE%), and MVO percentage (MVO%) were significantly associated with MVO (p < 0.05). Multivariate regression analysis identified LCR as an independent predictor of MVO [Odds Ratio = 0.18, 95% Confidence Interval (CI): 0.04–0.75, p = 0.019]. Receiver operating characteristic curve analysis demonstrated that LCR had predictive capability for MVO, with a sensitivity of 80.1% and specificity of 45.4% when the LCR value was 0.091 [area under the curve (AUC): 0.654, 95% CI: 0.609–0.700, p < 0.001]. A new predictive model incorporating LCR improved the prediction of MVO occurrence (AUC = 0.815, p < 0.001), with significant differences in net reclassification improvement (p = 0.004) and integrated discrimination improvement (p = 0.023) between the new and old models.Conclusion: A low LCR is an independent risk factor for MVO after PCI in STEMI patients. The predictive model incorporating LCR enhances the ability to predict MVO occurrence in patients with STEMI post-PCI.